Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Senti Biosciences Inc.’s current trading price is -85.59% away from its 52-week high, while its distance from the 52-week low is 34.99%. The stock’s price range during this period has varied between $0.27 and $2.53. The company, active in the Healthcare sector, saw a trading volume of around 0.67 million for the day, considerably lower average daily volume of 2.51 million observed over the last three months.
Senti Biosciences Inc. (SNTI) currently has a stock price of $0.36. The stock saw a sharp increase in the last trading session, hitting a high of $0.40 after opening at $0.39. The lowest recorded price for the day was $0.3384 before it closed at $0.40.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
Senti Biosciences Inc.’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $2.53 on 11/28/22, and the lowest price during the same period was recorded at $0.27 on 10/27/23.
How Financial Performance Impacts Market Capitalization
Senti Biosciences Inc. (SNTI) has experienced a quarterly decline of -41.74% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 16.24M and boasts a workforce of 122 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5698, with a change in price of -0.2487. Similarly, Senti Biosciences Inc. recorded 1,661,957 in trading volume during the last 100 days, posting a change of -40.55%.
How SNTI’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for SNTI stands at 0.45. Similarly, the long-term debt-to-equity ratio is also 0.42.
SNTI Stock Stochastic Average
As of today, the raw stochastic average of Senti Biosciences Inc. over the past 50 days is 16.36%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 16.36%. Additionally, the Stochastic %K and %D values for the company were 19.96% and 19.24%, respectively, over the past 20 days.
SNTI Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -74.14%.However, over the last six months, we can see a stronger performance of -61.63%. Over the last 30 days, the price of SNTI has fallen by 8.51%. And in the last five days, it has fallen by -15.99%.
